Proskauer on Advertising Law
Proskauer on Advertising Law

On Notice: FTC Issues Warning to Hundreds of Companies Regarding the Use of Fake Reviews and Other Misleading Endorsements in Online Marketing Campaigns

Prompted by the proliferation of social media advertising that often blurs the line between authentic content and sponsored posts, the Federal Trade Commission last week sent more than 700 companies a Notice of Penalty Offenses warning them against the use of deceptive endorsements in their online advertising.  The Notice advises recipient companies that engaging in advertising conduct the FTC has previously determined to be unfair, unlawful or deceptive under Section 5 of the FTC Act can subject them to civil liability of up to $43,792 per violation.  As we had previously predicted, these letters may reflect a shift in the FTC’s focus towards reliance on §5 of the FTC Act, following last term’s Supreme Court opinion in AMG Capital Mgmt. v. FTC which curtailed the FTC’s ability to seek monetary relief under §13(b) of the Act.

Companies receiving the Notice include large household names including leading retailers and major advertising agencies.  Recipients were also directed to distribute copies of the Notice to each of their subsidiaries engaged in the sale or marketing of products or services to consumers in the United States.  While the FTC makes clear that recipients of the Notice are not alleged to have engaged in any wrongdoing, the scope of the Notices sent out—and the Commission’s 5–0 vote to authorize the Notice and its distribution—demonstrates that the FTC is highly focused on the use of deceptive endorsements in online advertisements and is willing to aggressively pursue advertisers that flout its directives.

The Notice sent to companies provides a non-exhaustive list of practices the FTC has found to be unlawful in previous FTC administrative orders, including:

  • Falsely claiming an endorsement by a third party;
  • Misrepresenting whether an endorser is an actual, current, or recent user;
  • Using an endorsement to make deceptive performance claims;
  • Failing to disclose an unexpected material connection with an endorser;
  • Misrepresenting that an endorsement represents the experience, views, or opinions of users or purported users;
  • Misrepresenting that the experience of endorsers represents consumers’ typical or ordinary experience; and
  • Continuing to use an endorsement without good reason to believe that the endorser continues to subscribe to the views presented.

Copies of the case decisions discussed in the notice are available on the FTC’s website.  The Notice also points advertisers to additional resources, including a staff business guidance document The FTC’s Endorsement Guides: What People Are Asking¸ and the FTC’s Guides Concerning the Use of Endorsements and Testimonials in Advertising, 16 C.F.R. Part 255, for further guidance on their responsibilities under the FTC Act.

While navigating the evolving regulatory landscape regarding deceptive online advertising can present challenges for companies and their advertising partners, avoiding the practices outlined above will likely go a long way in mitigating the risk of facing an FTC enforcement action and subsequent liability.  Our team continues to monitor these changes and will apprise our readers of any FTC enforcement actions that arise as a result of the Notices issued today.  Watch this space for further developments.

***

Want to talk advertising? We welcome your questions, ideas, and thoughts on our posts. Email or call us at lweinstein@proskauer.com /212-969-3240.

 

“Butter” Luck Next Time: Court Finds California Cannot Preclude Vegan Dairy from Using “Vegan Butter” Labeling

Judge Richard Seeborg of the Northern District of California recently ruled in favor of Miyoko’s Kitchen in a suit concerning Miyoko’s labeling of its plant-based spread as “vegan butter.” In doing so, Judge Seeborg determined that absent evidence that the “vegan butter” label was false or would mislead consumers, the state of California could not restrict Miyoko’s constitutionally protected commercial speech. Miyoko’s Kitchen v. Karen Ross, Case No. 20-cv-00893 (N.D. Cal. August 10, 2021).

By way of background, in 2019, the California Department of Food and Agriculture notified Miyoko’s that the company’s labeling of its “vegan butter” violated state and federal law, and requested that Miyoko’s remove the following five claims: “hormone free,” “butter,” “lactose free,” “cruelty free,” and “revolutionizing dairy with plants.”  According to the Department, Miyoko’s marketing of its “vegan butter” gave the misleading impression that the product was a dairy product without traditional dairy characteristics.  In response, Miyoko’s filed a lawsuit against the State, arguing that the Department lacked the authority to regulate the company’s commercial speech under the First Amendment.  In December of 2020, the State filed a motion for summary judgment, and in March 2021, Miyoko’s filed a cross-motion for summary judgment.

In deciding the parties’ cross-motions, the court applied the Central Hudson standard applicable to the censorship of commercial speech.  Under Central Hudson, the court first must determine whether the restricted speech is misleading or related to unlawful activity.  If it is, the First Amendment does not apply, and the government is free to restrict the speech. If it is not, the restriction survives only if the censoring body “assert[s] a substantial interest to be achieved by [the] restriction,” and the restriction both directly advances that interest and is not more extensive than necessary.

Applying this standard, the court held that the First Amendment afforded Miyoko’s no basis for relief with respect to the “hormone free” claim.  Because the spread contains naturally occurring plant hormones, the claim is irrefutably false, and First Amendment protections do not apply.

But the court reached a different conclusion as to the “butter” claim, finding none of the State’s evidence of consumer confusion to be compelling. First, the State cited the FDA’s statutory definition of “butter,” arguing that because the statute has been on the books for ninety-odd years, it must be reflective of what consumers understand “butter” to mean. As the court noted, the FDA defines “butter” as a product “made exclusively from milk or cream, or both . . . and containing not less than 80 per centum by weight of milk fat.” Because Miyoko’s spread did not meet the dairy and fat-content requirements for the FDA’s statutory definition of “butter,” the State argued it did not comport with consumer understanding of the term. But the court was unmoved, noting that this argument “defies common sense” because “language evolves.” Absent any indication that “old federal food definitions are more faithful indicators of present-day linguistic norms,” the court found the federal definition of “butter” insufficient to make the State’s case..

The court was likewise unconvinced by the State’s consumer perception survey evidence, which indicated that consumers correctly identified plant-based cheese products 74% of the time. The State argued this indicates a 26% confusion rate, and shows that the label is misleading. However, the court observed that the State conveniently ignored the study’s other findings – including that consumers were only able to correctly identify animal-based cheese products 81% of the time. The court determined this survey does little other than suggest that “consumers are perhaps a bit better at identifying traditional cheese than vegan cheeses.”

Having found no compelling evidence of consumer confusion, the court rejected the State’s attempt to assert an interest in avoiding such confusion as a justification for restricting Miyoko’s labeling.  The court noted that any such confusion was mere speculation, and that “the record lacks material reasonably supporting the conclusion that removing ‘butter’ from Miyoko’s labeling ‘will in fact’ advance that interest ‘to a material degree.’”  The court applied the same logic to the remaining claims, finding that absent evidence that consumers are misled by Miyoko’s use of the claims, the State may not restrict Miyoko’s use of “lactose free,” “cruelty free,” and “revolutionizing dairy with plants.”

Advertisers can take some comfort in this decision; it serves as a reminder that the First Amendment gives advertisers the freedom to brand their products in creative or fanciful ways, so long as the advertising is not false, and as long as the government lacks a compelling interest that justifies limiting the speech.  But of course, government interference is hardly advertisers’ only concern; the risk of a consumer class action or a competitive advertising challenge (whether in court or at the National Advertising Division) is always in play.

***

Want to talk advertising? We welcome your questions, ideas, and thoughts on our posts. Email or call us at lweinstein@proskauer.com /212-969-3240.

Third Circuit Affirms Decision to Reject FTC’s False Advertising Claims Against Housing Insulation Company

A Third Circuit panel recently affirmed a Pennsylvania district court decision in favor of defendant Innovative Designs (“IDI”) in an advertising challenge by the FTC. We previously blogged about the district court decision, which found the FTC failed to present any credible expert testimony to support its claims. On appeal, the Third Circuit panel affirmed, finding  the FTC failed to show that IDI’s advertising claims were not scientifically supported. FTC v. Innovative Designs (3d Cir. July 22, 2021).

IDI manufactures and sells Insultex House Wrap, a weather-resistant barrier used in building construction. The insulation power of house wrap products is determined through the product’s R-value, a measure of the product’s ability to restrict the flow of heat. The higher the R-value, the higher the product’s insulation power. IDI advertised that Insultex had an R-value of either R-3 or R-6. The FTC alleged IDI overstated the R-value of its products because “(1) IDI did not use the standard ASTM C518 test to yield its purported R-values,” and standard ASTM C518 testing “did not yield IDI’s claimed results.” Instead of the standard ASTM C518 test, the FTC alleged IDI used a modified ASTM test to yield the advertised R-values.

The Court found that to prevail on a lack of substantiation theory, the FTC must identify the evidence that the advertiser should have to support its claim in the relevant scientific community, and then prove that the substantiation the advertiser claims to possess would not satisfy the relevant scientific community. Here, the Court found the FTC’s arguments failed because the FTC did not establish that the modified ASTM test did not comply with the standard ASTM C518 testing; the Court noted ASTM C518 testing explicitly contemplates that variations of the standard method may be acceptably used. In addition, the FTC failed to prove that the modified test would not satisfy the relevant scientific community, and failed to show “through expert testimony or otherwise” that the modified test yielded inaccurate results.  The Court clarified that the burden fell on the FTC to prove that the testing would not be acceptable to the relevant scientific community, not on IDI to prove that it would.

Like the district court decision, the Third Circuit’s opinion reinforces the importance of scientific evidence, including through a properly vetted expert witness, where the advertising claims at issue are highly technical, and where the FTC’s theory of falsity hinges on a lack of substantiation.

The Rise and Fall of “Vanilla” Labeling Challenges

Beginning in 2020, the advertising world saw an explosion of putative class-actions challenging the use of “vanilla” to describe products where the vanilla flavoring allegedly is not derived exclusively from the vanilla bean plant.  We previously blogged about several such cases. One plaintiff’s attorney alone, Spencer Sheehan, has filed—and continues to file—hundreds of these cases.  However, we suspect this trend will begin to subside, as courts have largely disposed of these cases at the pleading stage. Two recent decisions out of the Northern District of California and Eastern District of New York illustrate the challenges plaintiffs’ lawyers face in keeping these lawsuits afloat.  Garadi v. Mars Wrigley, No. 19-cv-03209-RJD-ST (E.D.N.Y. July 6, 2021); Fahey v. Whole Foods Market, Inc. et al., No. 20-cv-06737-JST (N.D. Cal. June 30, 2021).

In Fahey v. Whole Foods, plaintiff alleged that the labeling of Whole Foods’ 365 Organic Unsweetened Almond Vanilla Beverage was false and misleading because the vanilla flavor is derived from synthetic vanillin, rather than from the vanilla bean plant.  Similarly, in Garadi v. Mars Wrigley, plaintiffs alleged they were deceived by the word “vanilla” on the packaging of Dove-brand ice cream bars because the flavor does not come exclusively from vanilla beans or extract.  Plaintiffs in both cases contend they would not have purchased the products, or would have paid less, had they been aware of the true composition, and brought claims under the consumer protection laws of their respective states.

Citing district courts around the country, the court in Fahey held that the word “vanilla” standing alone (without any qualifying terms) would not be likely to mislead a reasonable consumer into believing that the product’s vanilla flavor came exclusively or predominantly from vanilla beans.  The court noted that its conclusion was bolstered by the fact that the product label lacked any phrases or images, such as “made with,” that would lead a reasonable consumer to understand “vanilla” to be referencing an ingredient rather than a flavor.  The court also concluded that survey data referenced by the plaintiff was not enough to overcome this deficiency, noting that plaintiff failed to provide any information about how the survey was conducted, what questions were asked, or how many consumers participated.  On these grounds, the court granted Whole Foods’ motion to dismiss.

In the same vein, the court in Garadi found that plaintiffs failed to plausibly allege that a reasonable consumer acting reasonably under the circumstances would be misled by the phrase “vanilla ice cream.”  Instead, the court found that the product’s label merely indicates that the ice cream is vanilla flavored.  Absent allegations that the ice cream does not taste like vanilla, the Garadi court also found plaintiffs’ claims to be ripe for dismissal.

These decisions are unsurprising, as numerous “vanilla” cases previously failed at the pleading stage.  However, while new “vanilla” cases may no longer be the “flavor of the month” among members of the plaintiff’s bar, we don’t expect flavor-related litigation to disappear any time soon. Plaintiffs’ lawyers have recently set their sights on claims involving other flavor profiles, such as “strawberry,” “fudge,” “smoked,” “lemon,” “butter,” and “lime.” Watch this space for further developments.

***

Want to talk advertising? We welcome your questions, ideas, and thoughts on our posts. Email or call us at lweinstein@proskauer.com /212-969-3240.

“Champion” Petfoods: Seventh Circuit Affirms Dismissal of False Advertising Suit Against Pet Food Company

We recently blogged about Champion Petfoods’ success in a Minnesota district court case alleging that it misrepresented the quality of its dog food and ingredients. Well, Champion Petfoods came back to defend its title in another case involving nearly identical allegations, this time in the Seventh Circuit. The Seventh Circuit recently affirmed a Wisconsin district court decision granting summary judgment in favor of Champion Petfoods. In doing so, the Court sent a loud message to contenders that “summary judgment is the proverbial ‘put up or shut up’ moment in a lawsuit.” Here, plaintiff’s failure to “put up” evidence in support of his claims cost him a shot at trial. Weaver v. Champion Petfoods USA Inc., No. 120-2235 (7th Cir. June 30, 2021).

Champion Petfoods’ packaging touts “biologically appropriate” dog food made with “fresh regional ingredients” prepared in their “award-winning kitchens”—“never outsourced.” Plaintiff alleged these claims were false and misleading because, according to plaintiff: 1) there is a risk that Champion’s dog food contains BPAs and pentobarbital; 2) Champion uses frozen ingredients, regrinds refreshed ingredients, and includes ingredients that are past their expiration date; 3) Champion receives ingredients from international sources like New Zealand, Norway, and Latin America—far away from its Canada and Kentucky kitchens; and 4) Champion purchases ingredients from third-party sources.

The Court, however, found plaintiff’s evidence insufficient to back his claims. In particular, the plaintiff provided neither consumer survey evidence nor expert testimony to support his liability case (though he submitted two expert reports on damages). Instead, plaintiff based his claims entirely on his own testimony. The Court found this was not enough to survive summary judgment.

First, plaintiff’s testimony alone was not enough to convince the Court that a reasonable consumer would believe “biologically appropriate” meant completely BPA-free, especially given (1) Champion does not add BPA to its dog food, and (2) humans and animals are commonly exposed to BPA. Champion also submitted unrebutted expert testimony that the levels of BPA in its food could not harm a dog. The Court also found plaintiff lacked standing to bring a claim that any dog food he purchased contained pentobarbital, because the sole source of any potential pentobarbital contamination would have come months after plaintiff stopped purchasing Champion’s dog food.

Plaintiff’s testimony was also insufficient to persuade the Court that a reasonable consumer would be misled into believing that “local and fresh ingredients” means the food contains exclusively local and fresh ingredients. The Seventh Circuit quoted the district court’s reasoning in Song v. Champion (a decision we previously blogged about), that “just as a statement that mashed potatoes are made with ‘real butter’ does not imply that the only fat used is real butter, and just as a statement that graham crackers are made with ‘real honey’ does not imply that the only sweetener used is real honey, so too the statement that a bag of dog food contains ‘fresh regional ingredients’ does not imply that it is composed exclusively of ingredients that are fresh and regional.” The Court thus found that Plaintiff’s own expectation that the dog food ingredients would come solely from regional sources was not enough to prove that other consumers were misled in the same way, especially since Champion never claimed its ingredients were 100% regionally sourced.

This case is a reminder that while class action plaintiffs sometimes are permitted to get away with “because I say so” at the pleading stage, far more is required at summary judgment.

***

Want to talk advertising? We welcome your questions, ideas, and thoughts on our posts. Email or call us at lweinstein@proskauer.com /212-969-3240.

 

Let it “Bee”: Ninth Circuit Affirms Dismissal of Trader Joe’s Manuka Honey Advertising Suit

A Ninth Circuit panel recently affirmed dismissal of a putative consumer class action alleging Trader Joe’s misleadingly labeled its store brand honey as “100% New Zealand Manuka Honey,” where plaintiffs’ pollen content testing showed that only about 60% of the honey was derived from Manuka flower nectar. In doing so, the Court reinforced the importance of considering context (including a reasonable consumer’s background knowledge) in evaluating whether advertising would be likely to mislead a reasonable consumer. Moore v. Trader Joe’s Co., No. 19-16618 (9th Cir. July 15, 2021).

Under the FDA’s Honey Guidelines, “Manuka Honey” is the “common or usual name” for honey whose “chief floral source” is the Manuka bush, a plant native to Australia and New Zealand. Plaintiffs conceded that Trader Joe’s labeling is consistent with these guidelines. Even still, plaintiffs maintained that “100% New Zealand Manuka Honey” could nonetheless mislead consumers into thinking that the honey was “100%” from Manuka flower nectar. As noted, plaintiffs commissioned pollen content testing that showed nearly half of the honey was derived from other non-Manuka flower nectar.

The Court of Appeals noted the “100%” in the “100% New Zealand Manuka Honey” label could be read in multiple ways: “100% could be a claim that the product was 100% Manuka honey, that its contents were 100% derived from the Manuka flower, or even that 100% of the honey was from New Zealand.” To determine if this ambiguity would mislead a reasonable consumer, the Ninth Circuit panel relied on precedent from multiple federal appellate courts supporting “the general principle that [courts considering] deceptive advertising claims should take into account all the information available to consumers and the context in which that information is provided and used.”  The panel also noted, “information available to a consumer is not limited to the physical label and may involve contextual inferences regarding the product itself and its packaging.”

Here, the Court found three key contextual inferences would dissuade a reasonable consumer from adopting the “unreasonable or fanciful” belief that the product consists solely of honey derived from the Manuka flower: (1) the impossibility of making a honey that is 100% derived from one floral source; (2) the low price of Trader Joe’s Manuka Honey; and (3) the presence of the “10+” on the label.

First, the Court explained that because of the well-known “foraging nature of bees” any reasonable consumer would know it is impossible to completely control what flowers a bee visits – making it impossible to produce a honey 100% derived from one floral source.

Second, the Court considered the price of Trader Joe’s Manuka Honey relative to the cost of products containing higher concentrations of Manuka-derived honey. Trader Joe’s honey costs $13.99 per jar ($1.59 per ounce), while a jar of honey 92% derived from Manuka costs around $266 ($21.55 per ounce). Given this dramatic price difference, the Court found any consumer aware of the market for Manuka honey could not reasonably expect a $13.99 jar of honey to be “100%” derived from Manuka flower nectar. In support of its reasoning, the Ninth Circuit cited the Second Circuit’s decision in Jessani v. Monini – a lawsuit where Proskauer successfully represented the makers of “white truffle flavored” olive oil. There, the Court found it was “simply not plausible that a significant portion of the general consuming public acting reasonably would conclude that [the defendant’s] mass produced, modestly-priced olive oil was made with ‘the most expensive food in the world.’”

Third, the Court turned to the “10+” on the product label. Although the Court noted there are “no other details on the jar about what ‘10+’ means, the presence of this rating on the label puts a reasonable consumer on notice that it must represent something about the product.” In fact, the “10+” refers to the honey’s Unique Manuka Factor (UMF) score, which measures a Manuka honey product’s concentration of honey derived from Manuka flower nectar. The Court observed that reasonable consumers of Manuka honey would routinely encounter such ratings and would likely have some knowledge about them – and any consumer with even a cursory knowledge of the UMF scale would know Trader Joe’s Manuka Honey was decidedly on the lower end of the scale, which ranges from 5+ to 26+.

The Court thus held “a reasonable consumer would be left only with the conclusion that ‘100% New Zealand Manuka Honey’ means that it is 100% honey whose chief floral source is the Manuka plant, which is an accurate statement.”

While some district courts in the Ninth Circuit can be unduly hesitant about dismissing at the pleading stage complaints alleging unreasonable interpretations of advertising, Moore is a reminder that “where plaintiffs base deceptive advertising claims on unreasonable or fanciful interpretations of labels or other advertising, dismissal on the pleadings may well be justified.”  Moore is also a reminder that in advertising law, context is king—or perhaps queen, in the case of the honey bee.

***

Want to talk advertising? We welcome your questions, ideas, and thoughts on our posts. Email or call us at lweinstein@proskauer.com /212-969-3240.

 

 

Court Considers FTC’s Ability to Seek Monetary Relief Post-AMG

Earlier this year, we blogged about the Supreme Court’s decision in AMG v. FTC, which significantly curtailed the FTC’s ability to seek monetary restitution under Section 13(b) of the FTC Act.  One quick update there: The U.S. House of Representatives recently voted to restore the FTC’s Section 13(b) disgorgement powers.  For now, though, in the absence of any action by the Senate, the FTC remains without that power.

Recently, Judge Dolly M. Gee of the District Court of the Central District of California considered the FTC’s post- AMG ability to seek monetary relief under a different provision of the Act. Though the court ultimately found the FTC could not do so on the particular facts of the case, Judge Gee’s decision left open the possibility that the FTC may, in theory, seek monetary relief under Section 19 of the FTC Act for violations of the Restore Online Shoppers’ Confidence Act (“ROSCA”). FTC v. Cardiff, No. 18-cv-2104 (C.D. Cal. June 29, 2021). However, because ROSCA claims are fairly limited in scope, this decision does not create the possibility of rendering the Supreme Court’s AMG decision a dead letter; there still exist substantial categories of FTC suits for which monetary relief is not permitted, absent an act of Congress.

The FTC alleged defendants, the marketers of smoking cessation products, enrolled consumers who purchased their products in a “monthly autoship program,” through which defendants shipped (and charged customers for) products without their consent. Based on these allegations, the FTC sued defendants under ROSCA, which prohibits charging consumers for goods sold online through an opt-out program unless consumers receive clear notice and a simple mechanism to cancel. Noting “[c]onsumers had to take an affirmative step to cancel the autoship program, and even when they took this step, they were not always able to effectuate a cancellation,” the court previously granted summary judgment to the FTC on its ROSCA claim. In the instant proceeding, the court considered damages owed to the FTC.

While the Supreme Court’s decision in AMG curtailed the FTC’s ability to seek restitution under Section 13(b), the FTC argued it could still seek monetary relief under Section 19. Section 19 authorizes the FTC to sue directly in federal court to obtain relief for unfair or deceptive acts or practices. Observing that Section 19 defines the available relief broadly, so as to include “the refund of money or return of property” and “the payment of damages,” the court agreed that the language in Section 19 plainly authorizes the FTC to seek equitable monetary relief to redress consumer injury resulting from ROSCA violations. It also noted that the Supreme Court’s decision in AMG explicitly stated that “[n]othing” in the decision “prohibits the Commission from using its authority under § 5 and § 19 [of the FTC Act] to obtain restitution on behalf of consumers.”

However, the court nonetheless denied the FTC’s ability to recover monetarily under Section 19 in this particular case, on the ground that the FTC failed to timely disclose its only evidence in support of its computation of ROSCA damages. The court noted that in its papers, the FTC only cited to Section 13(b) of the Act (not Section 19), and did not offer a separate calculation of damages for violations of ROSCA or any other statutes or rules. Finding that the FTC had put “all its eggs in the Section 13(b) basket,” the court determined it was too late for the FTC to pivot to Section 19 to recover damages.

Although the FTC did not succeed in obtaining monetary relief, it did succeed in obtaining injunctive relief against the defendants. The Court held that the FTC was permitted to seek a permanent injunction against defendants under Section 13(b) without first initiating administrative proceedings, because AMG only curtailed its ability to seek monetary relief under Section 13(b). Watch this space for further developments.

***

Want to talk advertising? We welcome your questions, ideas, and thoughts on our posts. Email or call us at lweinstein@proskauer.com /212-969-3240.

 

LexBlog

Proskauer and our platform provider LexBlog each use cookies to personalize content and ads, to provide social media features and to analyze traffic. Each of us also share information about your use of our site with our social media, advertising and analytics partners. If you are happy for us to store these cookies on your device please click 'Accept Cookies.' For more information, please see here and here.

OK